Key result
Novel rat LDL receptor minigene construct enables screening for LDL receptor activators.
Answers are grounded in this paper and cite their sources.
The majority of the low-density lipoprotein (LDL) receptors present in the body are expressed in the liver. Therefore, plasma LDL levels significantly correlate with changes in the activity of the hepatic LDL receptor. Based on this, there is a need to understand the regulatory mechanisms that control the hepatic expression of the low-density lipoprotein (LDL) receptor. Herein, we have prepared a functional rat LDL receptor minigene construct that can produce mRNA after splicing. Sequence analysis suggests that this construct has the potential to code for a truncated version of LDL receptor protein. This minigene could be used as a research tool to identify small molecules, natural products, and regulators of the LDL receptor gene that could be developed into LDL receptor-specific activators for therapeutic use.
No takes yet. Share an insight, caveat, or question.
Dayami Lopez (2019) studied this question. Functional rat LDL receptor minigene construct was evaluated on Production of spliced mRNA coding for a truncated LDL receptor protein. A functional rat LDL receptor minigene construct produced spliced mRNA coding for a truncated LDL receptor protein for use in screening LDL receptor activators.
Synapse has enriched 10 related papers. Consider them for comparative context: